Insider Buying Trends in the Vanguard Russell 2000 Value ETF
Overview of Insider Activity
Recent analysis of the Vanguard Russell 2000 Value ETF (VTWV) reveals that 10.2% of its weighted holdings have seen insider purchases in the last six months. This significant activity suggests that company executives and directors are actively investing in their own firms, which investors often interpret as a positive sign regarding future performance.
NBT Bancorp’s Insider Purchases
Among the notable companies within the Vanguard Russell 2000 Value ETF is NBT Bancorp Inc. (Ticker: NBTB). This company constitutes approximately 0.17% of the ETF’s assets. In the past six months, three insiders have made purchases, indicating a strong commitment from the company’s leadership. The total value of NBTB holdings within the ETF amounts to $1,355,456, ranking it as the 170th largest holding.
Recent Insider Buying at NBT Bancorp
| Date | Insider | Title | Shares Purchased | Price per Share | Total Value |
|---|---|---|---|---|---|
| 02/07/2025 | Heidi M. Hoeller | Director | 678 | $48.45 | $32,849 |
| 03/05/2025 | Scott Allen Kingsley | President & CEO | 2,000 | $44.90 | $89,800 |
| 04/29/2025 | Heidi M. Hoeller | Director | 2,553 | $43.21 | $110,315 |
| 05/06/2025 | Heidi M. Hoeller | Director | 2,588 | $42.88 | $110,973 |
| 06/03/2025 | Jason David Brown | Director | 350 | $41.10 | $14,385 |
Recent insider activity provides insights into the confidence level of the management in NBT Bancorp’s future prospects.
Ligand Pharmaceuticals’ Insider Insights
Another key player in the Vanguard Russell 2000 Value ETF is Ligand Pharmaceuticals Inc. (Ticker: LGND), which also represents about 0.17% of the ETF. Recent filings indicate that two directors and executives have reported their purchases through Form 4, reflecting their belief in the company’s trajectory. The ETF holds $1,348,958 worth of LGND, marking it as the 180th largest holding.
Insider Buying at Ligand Pharmaceuticals
| Date | Insider | Title | Shares Purchased | Price per Share | Total Value |
|---|---|---|---|---|---|
| 05/09/2025 | Todd C. Davis | Chief Executive Officer | 9,510 | $105.20 | $1,000,456 |
| 05/09/2025 | Octavio Espinoza | Chief Financial Officer | 1,500 | $104.06 | $156,090 |
The investments from executives at Ligand Pharmaceuticals highlight their confidence in the company’s strategic direction.
Implications of Insider Buying
The trend of insider purchasing in these companies can serve as a valuable indicator for potential investors. When executives buy shares, it often resonates positively with market sentiment, suggesting they are confident about the company’s future performance. This aspect can influence trading behaviors and investment decisions amongst current and prospective shareholders.
Conclusion
Tracking insider buying activities within ETFs like the Vanguard Russell 2000 Value can provide crucial insights into the confidence levels of a company’s leadership. As observed in the recent purchases by insiders at both NBT Bancorp and Ligand Pharmaceuticals, these actions may signal positive market conditions ahead, making it vital for investors to remain vigilant regarding insider trends.
